Literature DB >> 17644205

Chitosan and trimethyl chitosan chloride (TMC) as adjuvants for inducing immune responses to ovalbumin in mice following nasal administration.

Worawan Boonyo1, Hans E Junginger, Neti Waranuch, Assadang Polnok, Tasana Pitaksuteepong.   

Abstract

Chitosan of different molecular weights (Chi-P, MW=2.7x10(5) g/mol and Chi-A, MW=5.0x10(5) g/mol) and trimethyl chitosan chloride (TMC) of various degree of quaternization (DQ) including TMC-20, TMC-40 and TMC-60 were evaluated as adjuvants for inducing of immune responses to ovalbumin (OVA). OVA in solution and in alum were used as controls. Groups of BALB/c mice were immunized on days 0, 7 and 14. The IgG and IgA titers were examined on days 0, 13 and 21. It was found that for both days 13 and 21, Chi-A could elicit higher IgG responses to OVA than Chi-P. On day 13, OVA in TMC-40 induced IgG responses significantly higher than that in solution, Chi-P and TMC-60. Moreover, OVA in TMC-40 could induce IgG responses higher than OVA in alum. Although a significant difference was not observed at day 21, OVA in TMC-40 was shown to induce higher IgG responses than that in TMC-20, TMC-60 and solution. The IgA responses were the most pronounced on day 21. Again, Chi-A could elicite higher IgA responses than Chi-P and TMC-40 induced the highest IgA responses. In conclusion, these findings demonstrate that both MW of chitosan and DQ of TMC influence the level of immune induction. TMC-40 shows to be the most potent adjuvant for intranasal administration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17644205     DOI: 10.1016/j.jconrel.2007.05.025

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  13 in total

1.  Collagen type II and a thermo-responsive polymer of N-isopropylacrylamide induce arthritis independent of Toll-like receptors: a strong influence by major histocompatibility complex class II and Ncf1 genes.

Authors:  Akhilesh Kumar Shakya; Ashok Kumar; Dorota Klaczkowska; Malin Hultqvist; Kristin Hagenow; Rikard Holmdahl; Kutty Selva Nandakumar
Journal:  Am J Pathol       Date:  2011-09-18       Impact factor: 4.307

2.  Adjuvant properties of a biocompatible thermo-responsive polymer of N-isopropylacrylamide in autoimmunity and arthritis.

Authors:  Akhilesh Kumar Shakya; Ashok Kumar; Kutty Selva Nandakumar
Journal:  J R Soc Interface       Date:  2011-05-04       Impact factor: 4.118

3.  Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein.

Authors:  Anirban Sengupta; Mohammad Azharuddin; Maria E Cardona; Claudia Devito; Eleanore von Castelmur; Anna Wehlin; Zuzanna Pietras; Maria Sunnerhagen; Robert Selegård; Daniel Aili; Ali Alamer; Jorma Hinkula; Noha Al-Otaibi
Journal:  Vaccines (Basel)       Date:  2022-03-24

4.  Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphtheria toxoid formulations.

Authors:  Suzanne M Bal; Zhi Ding; Gideon F A Kersten; Wim Jiskoot; Joke A Bouwstra
Journal:  Pharm Res       Date:  2010-06-18       Impact factor: 4.200

Review 5.  Vaccine adjuvants: current challenges and future approaches.

Authors:  Jennifer H Wilson-Welder; Maria P Torres; Matt J Kipper; Surya K Mallapragada; Michael J Wannemuehler; Balaji Narasimhan
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

6.  Physicochemical and immunological characterization of N,N,N-trimethyl chitosan-coated whole inactivated influenza virus vaccine for intranasal administration.

Authors:  Niels Hagenaars; Enrico Mastrobattista; Rolf J Verheul; Imke Mooren; Harrie L Glansbeek; Jacco G M Heldens; Han van den Bosch; Wim Jiskoot
Journal:  Pharm Res       Date:  2009-02-18       Impact factor: 4.200

Review 7.  Trimethyl chitosan and its applications in drug delivery.

Authors:  V K Mourya; Nazma N Inamdar
Journal:  J Mater Sci Mater Med       Date:  2008-12-27       Impact factor: 3.896

8.  ZnO Nano-Rod Devices for Intradermal Delivery and Immunization.

Authors:  Tapas R Nayak; Hao Wang; Aakansha Pant; Minrui Zheng; Hans Junginger; Wei Jiang Goh; Choon Keong Lee; Shui Zou; Sylvie Alonso; Bertrand Czarny; Gert Storm; Chorng Haur Sow; Chengkuo Lee; Giorgia Pastorin
Journal:  Nanomaterials (Basel)       Date:  2017-06-15       Impact factor: 5.076

Review 9.  Novel application of trimethyl chitosan as an adjuvant in vaccine delivery.

Authors:  Anshu Malik; Manish Gupta; Vatika Gupta; Himanshu Gogoi; Rakesh Bhatnagar
Journal:  Int J Nanomedicine       Date:  2018-11-23

10.  Trimethyl Chitosan Nanoparticles Encapsulated Protective Antigen Protects the Mice Against Anthrax.

Authors:  Anshu Malik; Manish Gupta; Rajesh Mani; Himanshu Gogoi; Rakesh Bhatnagar
Journal:  Front Immunol       Date:  2018-03-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.